Displaying 161 - 165 of 180
Wed 19 September 2012
Pancreatic Cancer UK's report, entitled,"A cancer of unmet need: the pancreatic cancer research challenge", highlights an urgent need to redress a historical legacy of neglect surrounding investment into pancreatic cancer research in the UK. The charity is calling for a new approach to directing research investment into cancers of unmet need.Read More about 'New approach to pancreatic cancer research needed'
Fri 17 August 2012
We welcome the second National Cancer Patient Experience survey and the overall improvement in cancer patient experiences. However, we are concerned that Upper GI cancer patients still report areas of poor quality experience.Read More about 'New cancer patient experience results released'
Tue 24 July 2012
Research undertaken by a team at the University of East Anglia has found people with diets high in Vitamins C, E and the mineral Selenium are 67% less likely to develop pancreatic cancer.Read More about 'New research discovers vitamins that cut pancreatic cancer risk'
Tue 26 June 2012
Although most GPs could list one or two possible symptoms, half of those surveyed (49%) said that they were not confident that they could identify the signs and symptoms of possible pancreatic cancer in a patient.Read More about 'GPs lack the confidence and tools to spot the signs of pancreatic cancer'
Thu 24 May 2012
The Scottish Medicines Consortium (SMC) has approved everolimus (Afinitor®) for use within NHS Scotland in the treatment of neuroendocrine pancreatic cancer in adults with progressive disease.Read More about 'SMC approves drug for the treatment of neuroendocrine pancreatic cancer'